Laurence N Charney sold $755k of TGTX
director at TG THERAPEUTICS, INC.. 25,000 shares at an average of $30.20, traded Nov 11, 2024, filed Nov 12, 2024.
Score components
- +15RoleDirector
- +22Trade size$755k at market
- +5Share of holdings soldSold 11% of holdings
- +15Cluster3 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -0.7%, 3m +0.6%, 6m +8.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-24-034595, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 11, 2024 | SOpen-market sale Common Stock | -25,000 | $30.20 | $755k | 212,479 | Nov 12, 2024 |
| Nov 12, 2024 | GGift Common Stock | -5,000 | $0.00 | $0 | 207,479 | Nov 12, 2024 |
Related signals
Other insiders at TG THERAPEUTICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 28Weak | TGTXsell TG THERAPEUTICS, INC. | Laurence N Charney director | $275k 5,000 shares | -3% | |
| 26Weak | TGTXsell TG THERAPEUTICS, INC. | Yann Echelard director | $163k 5,000 shares | -2% | |
| 40Moderate | TGTXsell TG THERAPEUTICS, INC. | Sagar Lonial director | $672k 20,852 shares | -18% | |
| 30Weak | TGTXsell TG THERAPEUTICS, INC. | Yann Echelard director | $369k 10,000 shares | -4% | |
| 41Moderate | TG THERAPEUTICS, INC. | Sagar Lonial director | $152k 5,000 shares | -5% | |
| 48Moderate | TG THERAPEUTICS, INC. | Yann Echelard director | $490k 20,000 shares | -8% | |
| 32Weak | TG THERAPEUTICS, INC. | Sagar Lonial director | $80k 5,000 shares | -4% | |
| 38Weak | TG THERAPEUTICS, INC. | Laurence N Charney director | $351k 22,000 shares | -9% | |
| 38Weak | TG THERAPEUTICS, INC. | Laurence N Charney director | $333k 17,500 shares | -7% | |
| 52Moderate | TG THERAPEUTICS, INC. | Sean A Power CFO | $809k 47,867 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.